In TFIs without PTC-like NFs, immunoreactivity for PTC-associated biomarkers, such as mBRAF, HBME-1, and galectin-3, was only observed in two FTC cases that showed 53BP1 expression and primary FTC. The gene discussed is TP53BP1; the disease is thyroid cancer, nonmedullary, 2.